Condition 1: Polycystic ovarian syndrome. Condition 2: pregnancy. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group 1: this randomized clinical trial will be done on patients with poly cystic ovarian disease who randomly will be selected as intervention and control group . the con
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: presence of two of oligo/involution criteria clinical or laboratory based evidences of hyperendrogenism and polycystic ovaries in sonography
Exclusion criteria
Exclusion criteria: thyroid and prolactin dysfunction tubal abnormalities leading to infertility medium to severe semen fluid abnormalities of sperm quantity, mobility and shape leading to infertility presence of cysts(larger than 6 cm), history of asthma and usage of drugs influencing on glucose metabolism within 3 month before study entrance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of pregnancies. Timepoint: since the third day through seventh day after menstruation, 5 mg Letrozole was given to the group of control for 5 days and 5 mg Letrozole and 1200mg N-acetylcycteine were given to the group of intervention. Method of measurement: the structured checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSedigheh Mollashahi
Zahedan University of Medical Sciences
Outcome results
None listed